Literature DB >> 18419541

Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts.

Claudina A Pérez-Novo1, Anouk Waeytens, Cindy Claeys, Paul Van Cauwenberge, Claus Bachert.   

Abstract

BACKGROUND: Superantigens and eicosanoids are important amplifiers and regulators of inflammation in airway diseases. We therefore studied the possible influence of Staphylococcus aureus enterotoxin B (SEB) on the cyclooxygenase (COX) pathway and basic functions of airway structural cells.
METHODS: Fibroblasts were isolated from nasal inferior turbinate tissue and cultured in the presence of different concentrations of SEB. Preincubation with interferon (IFN)-gamma was performed to induce expression of major histocompatibility complex (MHC) class II receptors. Prostaglandin E2 (PGE(2)) production was assayed by enzyme-linked immunosorbent assay, and levels of COX-2 and prostanoid E receptors 1-4 (EP(1-4)) were assayed by real-time polymerase chain reaction. Migration and growth tests were performed, and SEB was localized within the cells by confocal microscopy.
RESULTS: Stimulation with IFN-gamma and SEB significantly down-regulated PGE(2), COX-2, and EP(2) expression but not EP(1), EP(3), or EP(4) expression. The enterotoxin blocked cell growth but increased the fibroblast migration rate. SEB was localized within the cell in the presence and absence of MHC-II, suggesting that mechanisms other than conventional binding may allow the enterotoxin to enter the cell.
CONCLUSIONS: These findings may have major implications for our understanding of the role played by bacterial superantigens in regulating the inflammatory and remodeling mechanisms of upper airway diseases and hence may help elucidate the pathophysiology of these diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419541     DOI: 10.1086/528989

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

Review 2.  The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis.

Authors:  Thad W Vickery; Vijay R Ramakrishnan; Jeffrey D Suh
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 3.  The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses.

Authors:  Kent Lam; Robert Schleimer; Robert C Kern
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

4.  Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.

Authors:  Jorge L Aguilar; Avanish K Varshney; Ximo Pechuan; Kaushik Dutta; Joshua D Nosanchuk; Bettina C Fries
Journal:  Virulence       Date:  2016-10-07       Impact factor: 5.882

5.  Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis.

Authors:  Ivy W Maina; Neil N Patel; Noam A Cohen
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-07-26

6.  Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis.

Authors:  Thad W Vickery; Michael Armstrong; Jennifer M Kofonow; Charles E Robertson; Miranda E Kroehl; Nichole A Reisdorph; Vijay R Ramakrishnan; Daniel N Frank
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-11-26       Impact factor: 4.006

7.  Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.

Authors:  Yuxia Wang; Biao Ren; Xuedong Zhou; Shiyu Liu; Yujie Zhou; Bolei Li; Yaling Jiang; Mingyun Li; Mingye Feng; Lei Cheng
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

8.  Staphylococcus aureus controls eicosanoid and specialized pro-resolving mediator production via lipoteichoic acid.

Authors:  Laura Miek; Paul M Jordan; Kerstin Günther; Simona Pace; Timo Beyer; David Kowalak; Verena Hoerr; Bettina Löffler; Lorena Tuchscherr; Charles N Serhan; Jana Gerstmeier; Oliver Werz
Journal:  Immunology       Date:  2022-03-09       Impact factor: 7.215

9.  Staphylococcus aureus and Chronic Airway Disease.

Authors:  Lara Derycke; Claudina Pérez-Novo; Koen Van Crombruggen; Marie-Noëlle Corriveau; Claus Bachert
Journal:  World Allergy Organ J       Date:  2010-08       Impact factor: 4.084

10.  Update on the management of chronic rhinosinusitis.

Authors:  Rachel B Cain; Devyani Lal
Journal:  Infect Drug Resist       Date:  2013-01-23       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.